Investment in, and new thinking on, Real World Evidence programmes for Obesity research: Real world data will be critical to understand the real, long-term value of the use of obesity agents, because it is clear that there is a highly diverse patient body, and social determinants of health are increasingly recognised as a crucial element in obesity research, because the role of the patient themselves in driving treatment outcomes is critical, especially when the patient pays for the obesity treatment out of pocket, and because of the importance that new digital technologies can have in collecting a broader range of data, including patient reported outcomes 16
Kieffer TJ, McIntosh CH, Pederson RA
The Key Role of Glutathione Compared to Curcumin in the Management of Systemic Lupus Erythematosus: A Systematic Review Kadry, M.O
You complete a health history and consent form
Selective novel inverse agonists for human GPR43 augment GLP-1 secretion